Back to Search
DAVID RIDER, M.D.
M.D.
Family Medicine Physician
NPI: 1326202185IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
M8283(TX)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON
Class of 2006
Research & Publications (20)
Polymorphisms in the FGF2 gene and risk of serous ovarian cancer: results from the ovarian cancer association consortium.
PMID 19456219·Twin Res Hum Genet·2009
8-other
Nucleotide excision repair pathway polymorphisms and pancreatic cancer risk: evidence for role of MMS19L.
PMID 19318433·Cancer Epidemiol Biomarkers Prev·2009
4-observational
Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer.
PMID 19276375·Cancer Res·2009
8-other
Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk.
PMID 19258477·Cancer Epidemiol Biomarkers Prev·2009
8-other
Polymorphisms in NF-kappaB inhibitors and risk of epithelial ovarian cancer.
PMID 19500386·BMC Cancer·2009
8-other
Nanostructured magnetic thin films from organometallic block copolymers: pyrolysis of self-assembled polystyrene-block-poly(ferrocenylethylmethylsilane).
PMID 19206626·ACS Nano·2008
8-other
Autocrine fibroblast growth factor 2 increases the multipotentiality of human adipose-derived mesenchymal stem cells.
PMID 18356575·Stem Cells·2008
8-other
Genetic variation in stromal proteins decorin and lumican with breast cancer: investigations in two case-control studies.
PMID 19036156·Breast Cancer Res·2008
8-other
Association of genetic variation in genes implicated in the beta-catenin destruction complex with risk of breast cancer.
PMID 18708403·Cancer Epidemiol Biomarkers Prev·2008
8-other
Genetic variation in the one-carbon transfer pathway and ovarian cancer risk.
PMID 18381459·Cancer Res·2008
8-other
Altered T-cell function in schizophrenia: a cellular model to investigate molecular disease mechanisms.
PMID 17668069·PLoS One·2007
7-preclinical
Redox-controlled micellization of organometallic block copolymers.
PMID 17971963·Chem Commun (Camb)·2007
8-other
A human CD4 monoclonal antibody for the treatment of T-cell lymphoma combines inhibition of T-cell signaling by a dual mechanism with potent Fc-dependent effector activity.
PMID 17942927·Cancer Res·2007
3-trial
A novel use of TAT-EGFP to validate techniques to alter osteosarcoma cell surface glycosaminoglycan expression.
PMID 17885814·J Mol Histol·2007
8-other
Selection using the alpha-1 integrin (CD49a) enhances the multipotentiality of the mesenchymal stem cell population from heterogeneous bone marrow stromal cells.
PMID 17694277·J Mol Histol·2007
8-other
Shell-cross-linked cylindrical Polyisoprene-b-polyferrocenylsilane (PI-b-PFS) block copolymer micelles: one-dimensional (1D) organometallic nanocylinders.
PMID 17411042·J Am Chem Soc·2007
8-other
Inherited variation in carcinogen-metabolizing enzymes and risk of colorectal polyps.
PMID 16926176·Carcinogenesis·2007
8-other
Carbon nanotubes with small and tunable diameters from poly(ferrocenylsilane)-block-polysiloxane diblock copolymers.
PMID 16700610·Langmuir·2006
8-other
Identification of valid housekeeping genes and antioxidant enzyme gene expression change in the aging rat liver.
PMID 16456191·J Gerontol A Biol Sci Med Sci·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1414 EAST WALNUT
SEGUIN, TX 78155 - Phone
- (830) 379-7901
Quick Facts
- NPI
- 1326202185
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 20
- Publications
- 20
Are you this provider?
Claim Your Profile